Novartis Nears Deal to Buy Cholesterol-Drug Maker The Medicines Co. | wsj.com
Acquisition would help Novartis bulk up in the heart-treatments market Por Dana Cimilluca, Cara Lombardo and Jonathan D. Rockoff Novartis AG is nearing a deal to buy cholesterol-drug maker The Medicines Co. for nearly $7 billion, in an expensive bid to expand its reach in […]
- Rassegna Stampa America economia